Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia.

Metabolism: clinical and experimental - 1 May 1998

Sanllehy C, Casals E, Rodriguez-Villar C, Zambón D, Ojuel J, Ballesta A M, Ros E

Abstract excerpt

The magnitude of serum lipid changes in response to hypolipidemic drugs varies considerably between individuals. These differences may be due to interactions between genetic and environmental factors that effect drug bioavailability or the capacity of the lipid-regulating enzyme and receptor targets to be affected. The apolipoprotein E (apoE) gene locus has been examined in this regard, but reports are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Data Interpretation, Statistical

Share to Drug Interactions

Share to Hypercholesterolemia

Share to Lipoproteins

Share to Phenotype

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 9591747
DOI: 10.1016/s0026-0495(98)90240-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia.PMID 9591747Read ↗

Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events.Semantic proximity Read ↗

The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.Semantic proximity Read ↗

The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism.Semantic proximity Read ↗

The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.Semantic proximity Read ↗

Apolipoprotein E and complement C3 polymorphism and their role in the response to gemfibrozil and low fat low cholesterol therapy.Semantic proximity Read ↗

Effect of apolipoprotein E genotypes on the efficacy of ezetimibe monotherapy in patients with statin induced adverse effects.Semantic proximity Read ↗

Influence of apolipoprotein E polymorphism on bezafibrate treatment response in dyslipidemic patients.Semantic proximity Read ↗

Dietary treatment of hypercholesterolaemia: lack of relationship between individual response and genetic variation at the lipase loci. The Fluvastatin Genotyping Group.Semantic proximity Read ↗

Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.